LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.68 | 21.74 | 2903 | 3418 | 0.8491 | 0.9557 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.68 | 21.74 | 3401 | 3418 | 0.9948 | 0.9986 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.65 | 21.74 | 63 | 3754 | 0.0168 | 0.1539 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.65 | 21.74 | 4931 | 3754 | 1.3135 | 1.0747 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.65 | 21.74 | 2756 | 3754 | 0.7341 | 0.9185 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.65 | 21.74 | 3730 | 3754 | 0.9936 | 0.9983 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.62 | 21.74 | 52 | 4150 | 0.0125 | 0.1220 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.62 | 21.74 | 5332 | 4150 | 1.2846 | 1.0672 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.62 | 21.74 | 3321 | 4150 | 0.8001 | 0.9420 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.62 | 21.74 | 4051 | 4150 | 0.9759 | 0.9936 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.59 | 21.74 | 39 | 4492 | 0.0087 | 0.0790 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.59 | 21.74 | 5666 | 4492 | 1.2613 | 1.0613 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.59 | 21.74 | 3279 | 4492 | 0.7300 | 0.9198 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.59 | 21.74 | 4388 | 4492 | 0.9768 | 0.9939 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.56 | 21.74 | 27 | 4838 | 0.0056 | 0.0282 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.56 | 21.74 | 6114 | 4838 | 1.2635 | 1.0609 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.56 | 21.74 | 3295 | 4838 | 0.6810 | 0.9038 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.56 | 21.74 | 4765 | 4838 | 0.9848 | 0.9961 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.53 | 21.74 | 38 | 5150 | 0.0074 | 0.0734 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.53 | 21.74 | 6534 | 5150 | 1.2685 | 1.0612 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.53 | 21.74 | 3235 | 5150 | 0.6281 | 0.8855 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.53 | 21.74 | 5028 | 5150 | 0.9762 | 0.9939 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.50 | 21.74 | 26 | 5425 | 0.0048 | 0.0227 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.50 | 21.74 | 6985 | 5425 | 1.2874 | 1.0645 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.50 | 21.74 | 2721 | 5425 | 0.5015 | 0.8340 | MN20160310_N01 | M03 |